Family member DYRK1B has demonstrated a strong increase when tumor cells exit the cell cycle upon mitogen deprivation or the pharmacological inhibition of proliferative pathways in different cancer cell types (breast, colon carcinoma, melanoma, pancreatic, and ovarian cancer cells) [102,103,104]. The gene discussed is DYRK1B; the disease is cancer.